Pharmacology Introduction Flashcards
pharmacokinetics
effects of body on the drug (1. absorption 2. distribution 3. metabolism 4. elimination)
pharmacodynamics
effects of drug on body (1. receptor binding 2. signal transduction 3. physiological effect)
where do drugs come from?
natural: plant derived like digoxin, quinine, morphine or biologics like insulin or cytokines
semisynthetic: hydromorphone
synthetic: fentanyl
Phase 1
i have a drug, it looks like it works in animals, im going to give it to 20-100 normals. Is it safe? What are its kinetics
Phase 2
does the drug work? Im going to give it to 20-100 patients
Phase 3
how well does it work? randomized trial with 100+ patients comparing it to something thats out there or to placebo
phase 4
postmarket surveillance
Overall process
you do some pre-clinical research and you develop a drug and test it in animals (average of about 18 months)
then you submit the IND
then you begin clinical trials and development (phase 1,2,3) and that takes an average of about 5 years
then you submit the NDA- takes an average of 2 years
then you can go to post-market surveillance
Drug names
chemical (we don’t use)
non-proprietary (generic) (adopted)
trade/ proprietary name
There are some naming conventions that we have like:
-olol = beta blocker
-mab = monoclonal antibody
but for the rest it can get confusing and a mistake can be made if medications sound or look the same SO use the adopted name AND the proprietary name AND write what the med is indicated for AND use tall-man letter to prevent confusion
bioavailability
the amount of drug that reaches the blood
bioavailability with IV
Given by IV- bioavailability = 100% because im squirting it right into your blood
why do they say to put NTG under your tongue if you are having chest pain?
Because you have veins under your tongue that drain right into the systemic circulation (instead of going to the liver through first pass metabolism)
factors that affect bioavailability
gastric emptying/ food
properties of the drug like dissolution and disintegration
dosage form (enteric coated formulations)
chemical formulation
first pass metabolism
you take a pill and the first things that happens…
disintegration and this can be slowed by product formulation like sustained release with enteric coating
then as it is doing this process, the second thing that happens is
it dissolves. and all the things that can affect solubility can affect it here:acidic pH for weak acids, water solubility, large particle size
after the drug dissolves it can be…
absorbed
and once the drug is absorbed it goes through…
first pass metabolism in the liver before it can reach your systemic circulation
absorption can be slowed by
decreased gastric emptying,
increased ionized drug pyloroplasm
fast small intestine transit time
decreased mesenteric blood flow
distribution
where in the body does the drug reside and what factors change that
1 compartment model of apparent volume of distribution
put a pill in a bucket (the body), measure the concentration, and you can find the size of the bucket; we call it apparent because we arent buckets and in reality it is just theoretical
how does vd work with regard to amount found in blood
large vd means that the drug doesnt reside in the blood (maybe it is in the ECM or the total body water/ fat). but the smaller the Vd the more you will find of that drug in the blood
[drug mg/L] = s x f x dose (mg) / Vd
S = % of the drug that is not in salt form so if only 20% of the drug is actually drug because the rest is salt then that is .2 F = bioavailability- if we know things arent well absorbed we can correct for that; for IV f is always 1
useful for risk assessment
1 compartment
immediate distribution
2 compartment
slow distribution into a particular region
half life is talking about what phase
the terminal elimination phase with the slope B because in the beginning we have absorption and distribution going on
whats the difference between asking about half life and duration of effect
half life is asking a mathematical question. the clinical correlate is the duration of the effect
what decides where a drug goes?
lipophilicity
protein binding
pH (development of charge)
total body water =
.6 L/kg (4 in plasma, 10 in interstitial fluid, 28 in intracellular fluid)
Sites of distribution
total body water (.6L/kg) (4 L in plasma, 10 in interstitial fluid, 28 in intracellular fluid), fat, soft tissue, bone
Lipophilicity
some drugs live in fat, some drugs live in water
octanol/water partition coeffecient
log P
log d
log P at physiological pH
Protein binding
some drugs are bound to proteins in the blood and when they are they cannot leave- they stay there in the blood some drugs (acidic ones) like albumin; other basic drugs like alpha1-acid glycoprotein change in protein concentration for drugs bound to protein can result in a dramatic change in biological effect by altering distribution
pH and charge
charged molecules dont cross membranes well because membranes are fatty spaces and charges increase water solubility
weak acids and bases can be affected by
pH, which can affect their movement through biological membranes